Moderator: Ken Yale, DDS, JD, Active Health Management Panelists: Eric Lai, Ph.D, Takeda Pharmaceuticals, Gary Palmer, M.D., J.D., MBA, MPH, Chief Medical Officer, NantHealth, Razelle Kurzrock, MD - UCSD, Jose Florez, MD, PhD, Harvard Medical School, Peter Ganz, MD, UCSF
Different disease indications are considered and treated by patients and clinicians respectively, from a siloed, population-based perspective. The symtomatology, diagnosis, treatment and prognosis present unique challenges for each disease indication. How can precision medicine bring clarity to such complex malfunctioning biological systems of any disease indication? Can cross-consideration of disease areas fertilize our thinking of diagnosis and treatment at the individual patient level? Experts in cardiovascular, metabolic, neurologic and oncologic disease will debate and discuss in this panel session.